Leukapheresis cell concentration adjustment required for a successful recovery of HSC after cryopreservation.


Journal

Cryobiology
ISSN: 1090-2392
Titre abrégé: Cryobiology
Pays: Netherlands
ID NLM: 0006252

Informations de publication

Date de publication:
01 02 2020
Historique:
received: 27 07 2019
revised: 26 09 2019
accepted: 26 09 2019
pubmed: 30 9 2019
medline: 21 10 2020
entrez: 30 9 2019
Statut: ppublish

Résumé

The recovering of an adequate number of hematopoietic stem cells after cryopreservation is considered pivotal for successful transplantation. Various factors could influence the recovery of HSC following processing and cryopreservation. Therefore, leukapheresis product from thirty patients was cryopreserved in 10% DMSO in cryopreservation bags for their autologous bone marrow transplantation, and 2 ml were cryopreserved in cryovials for post-thaw viability assessment by flow cytometry. The percentage of viable HSCs recovered post-cryopreservation in leukapheresis product was significantly influenced by the concentration of the total nucleated cells cryopreserved per volume. Patients receiving a higher rate of viable HSCs resulted in earlier engraftment of both neutrophils and platelets, so they have been discharged earlier from the hospital. Furthermore, Storage temperature and duration played a role in the recovery of these cells and for the support of the findings, age of the patient at the time of collection did not show any impact on the recovery of this HSC post-cryopreservation. In conclusion, various influencing factors must be taken into consideration during the cryopreservation of HSCs, especially for poor mobilizing patients with a low number of collected hematopoietic stem cells.

Identifiants

pubmed: 31563591
pii: S0011-2240(19)30235-4
doi: 10.1016/j.cryobiol.2019.09.011
pii:
doi:

Substances chimiques

Antigens, CD34 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-25

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The Authors declare no conflict of interest.

Auteurs

Rebar N Mohammed (RN)

Bone Marrow Transplant Center, Hiwa Cancer Hospital, Kurdistan, Iraq; Department of Microbiology, College of Veterinary Medicine, University of Sulaimani, Kurdistan, Iraq. Electronic address: rebar.mohammed@univsul.edu.iq.

Dereen Ahmad (D)

Bone Marrow Transplant Center, Hiwa Cancer Hospital, Kurdistan, Iraq.

Najmaddin Khoshnaw (N)

Bone Marrow Transplant Center, Hiwa Cancer Hospital, Kurdistan, Iraq; Department of Hematology, Kurdistan Board for Medical Specialties, Erbil, Kurdistan Region, Iraq.

Dastan O Hassan (DO)

Bone Marrow Transplant Center, Hiwa Cancer Hospital, Kurdistan, Iraq.

Hanar A Abdulrahman (HA)

Research Center, Polytechnic University of Sulaimani, Iraq.

Michele Vacca (M)

Ospedale San Camillo, and Salvator Mundi International Hospital-University of Pittsburgh Medical Center, Rome, Italy.

Marco Possenti (M)

Ospedale San Camillo, and Salvator Mundi International Hospital-University of Pittsburgh Medical Center, Rome, Italy.

Diana Faruq (D)

Bone Marrow Transplant Center, Hiwa Cancer Hospital, Kurdistan, Iraq.

Harem Omer (H)

Bone Marrow Transplant Center, Hiwa Cancer Hospital, Kurdistan, Iraq.

Salah Muhamad (S)

Bone Marrow Transplant Center, Hiwa Cancer Hospital, Kurdistan, Iraq.

Ignazio Majolino (I)

Bone Marrow Transplant Center, Hiwa Cancer Hospital, Kurdistan, Iraq; Ospedale San Camillo, and Salvator Mundi International Hospital-University of Pittsburgh Medical Center, Rome, Italy.

Dosti N Othman (DN)

Bone Marrow Transplant Center, Hiwa Cancer Hospital, Kurdistan, Iraq; Department of Hematology, Kurdistan Board for Medical Specialties, Erbil, Kurdistan Region, Iraq.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH